GuangYuYuan(SH:600771)2017-04-25 16:00Financial Performance - Net profit attributable to shareholders increased by 199.66% to CNY 24,250,041.19 year-on-year[7] - Operating revenue rose by 6.33% to CNY 201,579,716.81 compared to the same period last year[7] - Total profit and net profit attributable to the parent company increased by CNY 9.2292 million and CNY 16.1575 million, with growth rates of 34.07% and 199.66% respectively, due to improved cost control and reduced sales expense ratio[19] - Operating profit for the same period was ¥35,486,597.08, up from ¥27,875,069.95, reflecting a growth of 27.5%[35] - Basic earnings per share for Q1 2017 were ¥0.07, compared to ¥0.029 in the same quarter last year, reflecting a growth of 141.4%[36] Assets and Liabilities - Total assets decreased by 2.93% to CNY 2,080,011,942.09 compared to the end of the previous year[7] - Total assets at the end of the reporting period amounted to ¥2,905,117,357.64, slightly up from ¥2,903,692,412.88 at the beginning of the year[32] - Current liabilities totaled ¥117,553,731.34, an increase from ¥112,549,593.93 at the start of the year, representing a rise of 4.0%[32] - The total liabilities increased to ¥127,553,731.34 from ¥122,549,593.93, indicating a growth of 4.1%[32] - Short-term borrowings decreased by CNY 40 million, a reduction of 96.78%, as the company repaid loans from a bank[15] Cash Flow - Cash flow from operating activities showed a net outflow of CNY 156,470,625.96, worsening from a net outflow of CNY 45,997,785.24 in the previous year[7] - Operating cash flow decreased by CNY 110.4728 million compared to the same period last year, influenced by increased marketing and salary expenses[19] - The net cash flow from operating activities was -156,470,625.96 RMB, a significant decline compared to -45,997,785.24 RMB in the previous period, indicating a worsening cash flow situation[43] - Cash inflow from operating activities totaled 101,776,435.09 RMB, down from 138,386,375.49 RMB, reflecting a decrease of approximately 26.4%[43] - Cash outflow from operating activities increased to 258,247,061.05 RMB from 184,384,160.73 RMB, representing a rise of about 40%[43] Investments - The company invested CNY 97,296,600 in projects including the Traditional Chinese Medicine Industrial Park and R&D center[13] - Development expenses increased by CNY 4.0044 million, a growth of 768.40%, mainly due to investments in quality improvement research and technology promotion projects totaling CNY 2.9343 million[15] - The company made significant investments totaling 300,000,000.00 RMB, compared to 351,290,000.00 RMB in the previous period, indicating a reduction in investment spending[44] Shareholder Information - The number of shareholders reached 15,148, with the largest shareholder holding 23.22% of shares[11] Inventory and Receivables - Inventory increased by 43.29% to CNY 14,563,000 due to procurement of high-value raw materials[14] - Other receivables increased by 216.49% to CNY 8,800,000, primarily due to marketing activity funding[14] - Other non-current assets increased by CNY 13.0535 million, a growth of 40.08%, primarily due to prepayments for land purchases amounting to CNY 12.9510 million[15] - Accounts payable increased by CNY 34.2958 million, a growth of 49.32%, mainly due to outstanding payments for raw materials[15] Future Outlook - The company expects cumulative net profit for the year to increase by over 100% compared to the same period last year due to enhanced market activities and brand effects[22]